12 yo with Hand, Foot , and Mouth - Nursing Case Study

Pathophysiology

• Primary mechanism: Hand, Foot, and Mouth Disease (HFMD) is primarily caused by the Coxsackievirus A16 or Enterovirus 71, which invade the body through the oral or respiratory route, leading to viral replication in the mucosal tissues and lymph nodes.

• Secondary mechanism: The virus disseminates through the bloodstream, causing a systemic infection characterized by vesicular lesions on the hands, feet, and oral mucosa due to viral-induced cytolysis of epithelial cells.

• Key complication: In moderate cases, the virus can lead to aseptic meningitis, where the virus infects the central nervous system, causing fever, headache, and neck stiffness, requiring prompt medical attention.

Patient Profile

Demographics:

12 years old, male, student

History:

• Key past medical history: Mild asthma, no previous hospitalizations

• Current medications: Inhaler (Albuterol) as needed for asthma

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Rash and fever

• Key symptoms: Painful sores in mouth, rash on hands and feet, decreased appetite, irritability, mild dehydration

• Vital signs: Temperature 102.4°F, heart rate 110 bpm, respiratory rate 24 breaths per minute, blood pressure 100/60 mmHg

Section 1

As the clinical team continues to monitor the 12-year-old male patient with Hand, Foot, and Mouth Disease, they note a change in his status. Over the past 24 hours, he has developed new symptoms including a worsening headache, neck stiffness, and increased irritability. His fever remains elevated at 103°F despite antipyretic administration, and his heart rate has increased to 120 bpm. The patient is also experiencing photophobia, which is a new development. Given these symptoms, the clinical team is concerned about the possibility of aseptic meningitis, a known complication of HFMD.

In response to these changes, the healthcare providers initiate a more detailed neurological examination and decide to perform a lumbar puncture to evaluate for viral meningitis. Initial findings from the cerebrospinal fluid analysis reveal an elevated white blood cell count with a predominance of lymphocytes, consistent with viral meningitis. Additionally, the CSF glucose level is within normal limits, and protein levels are mildly elevated. These findings, coupled with the patient's clinical presentation, support the diagnosis of aseptic meningitis secondary to the viral infection.

The clinical team begins supportive care measures, including maintaining hydration with intravenous fluids and managing the patient's pain and fever. They also consult with a neurologist to ensure comprehensive care and consider antiviral therapy options. As the team discusses the implications of this complication, they emphasize the importance of monitoring for any further neurological changes and maintaining vigilant supportive care to prevent additional complications. The next phase of care will focus on close observation and adjusting the treatment plan as necessary based on the patient's response and any new developments.

Section 2

As the clinical team continues to monitor the 12-year-old patient, they observe a change in his status over the next 48 hours. Despite initial supportive care measures, the patient exhibits increased lethargy and difficulty waking. His parents report that he is sleeping more than usual and is less responsive when awake. The latest set of vital signs reveals that his fever has slightly reduced to 101°F, but his heart rate remains elevated at 118 bpm. His blood pressure is stable at 110/70 mmHg, but his respiratory rate has increased to 24 breaths per minute, indicating a potential compensatory response to increased metabolic demands or discomfort.

A repeat neurological examination reveals persistent neck stiffness and a new finding of mild ataxia, with the patient experiencing slight difficulty in coordinating movements when asked to perform simple tasks such as finger-to-nose testing. The presence of ataxia raises concerns about potential cerebellar involvement or increased intracranial pressure. In response to these findings, the team orders further imaging studies, including a CT scan of the head, to rule out any structural abnormalities or complications such as cerebral edema.

Laboratory results show a slight increase in inflammatory markers, with a C-reactive protein level of 15 mg/L and a mild leukocytosis with a white blood cell count of 12,000/μL. The team decides to intensify monitoring and maintain a lower threshold for escalating care if his neurological status deteriorates further. Discussions with the neurologist focus on the potential need for more aggressive interventions, such as corticosteroids or additional antiviral therapy, should imaging or clinical findings suggest worsening cerebral involvement. The team remains vigilant, recognizing the critical importance of early intervention in preventing severe neurological complications.

Section 3

As the clinical team continues to closely monitor the 12-year-old patient, they receive the results of the CT scan of the head. The imaging reveals mild cerebral edema but no significant structural abnormalities, such as hemorrhage or mass effect. This finding suggests that the neurological symptoms may be attributed to inflammation associated with the viral infection. In light of these results and the patient's persistent ataxia and lethargy, the team discusses the potential benefits and risks of initiating corticosteroid therapy to reduce cerebral edema and inflammation. The neurologist recommends a cautious approach, considering the potential for immunosuppression, but acknowledges that the benefits may outweigh the risks given the patient's current neurological status.

Meanwhile, the nursing team conducts ongoing assessments and notes that the patient continues to exhibit increased respiratory effort, with a respiratory rate now at 26 breaths per minute. His oxygen saturation remains stable at 96% on room air, but the team remains vigilant for any signs of respiratory compromise. The patient's heart rate has decreased slightly to 112 bpm, but he still appears lethargic and difficult to rouse. The parents express concern about his prolonged drowsiness and the new onset of occasional headaches, which may be indicative of increased intracranial pressure.

The decision is made to initiate a low-dose corticosteroid regimen while monitoring for any adverse effects. The team also considers starting an antiviral therapy, given the possibility of ongoing viral replication contributing to systemic and neurological symptoms. In conjunction with these interventions, the nursing staff prioritizes careful monitoring of neurological status, vital signs, and respiratory function, ensuring timely identification of any further complications. The plan includes educating the family on signs of deterioration and keeping them informed about the rationale and goals of the current treatment strategy. Through these steps, the clinical team aims to stabilize the patient's condition and prevent progression to more severe complications, while remaining prepared to escalate care as needed.

Section 4

As the corticosteroid regimen begins, the nursing team closely monitors the patient's response to the intervention. Within the first 24 hours, there is a noticeable improvement in the patient's neurological symptoms. His ataxia has slightly diminished, and he appears more alert and responsive during assessments. However, the team is cautious, aware that corticosteroids can mask symptoms without addressing the underlying viral etiology. The decision to initiate antiviral therapy is made to target potential viral replication, and the patient is started on an appropriate medication, with the expectation that it may further reduce systemic viral load and alleviate symptoms.

Despite these improvements, the patient develops a new complication: mild tachycardia, with a heart rate now consistently around 130 bpm. While his blood pressure remains stable at 110/70 mmHg, and his respiratory rate decreases to 22 breaths per minute, the team is concerned about the potential causes of the increased heart rate. Differential diagnoses include side effects of corticosteroid administration, dehydration, or a compensatory response to subclinical hypoxia. A thorough assessment is conducted, including an evaluation of fluid status, electrolyte balance, and a repeat chest assessment to rule out evolving respiratory issues. Lab tests reveal mild hypokalemia, likely secondary to corticosteroid therapy and previous fluid shifts related to his illness.

To address the hypokalemia, the team initiates potassium supplementation and increases fluid intake, carefully balancing the need to prevent fluid overload given the cerebral edema. The patient is also placed on continuous cardiac monitoring to track any further changes in heart rate or rhythm. The family is updated on the current status and the steps being taken to address these new findings. As the clinical team navigates these developments, they remain vigilant for any signs of deterioration, ready to escalate care if necessary, while focusing on stabilizing the patient's condition to facilitate recovery.

Section 5

As the nursing team continues to monitor the patient, a new complication emerges: mild respiratory distress. Despite the stable respiratory rate, the patient exhibits increased work of breathing, evidenced by mild intercostal retractions and nasal flaring. Auscultation reveals diminished breath sounds at the lung bases, suggesting possible atelectasis or early pulmonary edema. The patient's oxygen saturation, previously stable at 96%, has decreased to 93% on room air, prompting the administration of supplemental oxygen via nasal cannula to maintain adequate oxygenation.

In light of these developments, the team orders a chest X-ray to assess for any signs of pneumonia, atelectasis, or fluid overload. The results confirm the presence of mild atelectasis in the lower lobes, likely secondary to reduced mobility and shallow breathing due to discomfort. The team recognizes the importance of addressing this issue promptly to prevent further respiratory compromise. An incentive spirometer is introduced to encourage deep breathing exercises, and the patient's activity level is gradually increased as tolerated to promote lung expansion.

The patient's response to these interventions is closely monitored, with a focus on improving respiratory function and preventing progression to more severe complications. The clinical team continues to communicate with the family, providing updates on the patient's condition and the rationale for the current treatment plan. By maintaining a proactive approach, the team aims to stabilize the patient's respiratory status and support continued recovery from hand, foot, and mouth disease, while remaining vigilant for any additional complications that may arise.